公司资料
Eloxx 股价、新闻与催化剂
- 股票代码:
- ELOX
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
19.99 USD (-4.70%)
收盘价
最后更新: 2026年8月24日
—
市值
股价为何变动
As of Aug 24, 2026, ELOX closed down 4.70% at $19.99. No new same-company headline was identified in the current news window.
公司概览
业务概览
Eloxx Pharmaceuticals was a biotechnology company focused on rare disease and nonsense-mutation biology. Its story was built around precision approaches to difficult inherited disorders.
所在地与行业分类
Eloxx was headquartered in the United States and listed on NASDAQ. It sat in rare-disease biotechnology.
商业模式特征
The business depended on translational progress, clinical validation, and the ability to keep a narrow pipeline funded. Investors generally watched early data and strategic changes.
生物医药行业定位
Eloxx occupies the historical rare-disease biotech bucket. Its value proposition was always tied to limited assets and the market's patience for development risk.
未来催化剂
- Eloxx’s catalysts are its nonsense-mutation and rare-disease pipeline, plus any update that clarifies whether the company can still keep the translational story alive. The next step matters because the company still needs clinical proof.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。